| Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota W Fusco, MB Lorenzo, M Cintoni, S Porcari, E Rinninella, F Kaitsas, ... Nutrients 15 (9), 2211, 2023 | 332 | 2023 |
| Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases G Ianiro, M Punčochář, N Karcher, S Porcari, F Armanini, F Asnicar, ... Nature Medicine 28 (9), 1913-1923, 2022 | 187 | 2022 |
| Fecal microbiota transplantation: screening and selection to choose the optimal donor S Bibbò, CR Settanni, S Porcari, E Bocchino, G Ianiro, G Cammarota, ... Journal of Clinical Medicine 9 (6), 1757, 2020 | 121 | 2020 |
| Key determinants of success in fecal microbiota transplantation: From microbiome to clinic S Porcari, N Benech, M Valles-Colomer, N Segata, A Gasbarrini, ... Cell host & microbe 31 (5), 712-733, 2023 | 114 | 2023 |
| Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study G Vanella, G Capurso, C Burti, L Fanti, L Ricciardiello, AS Lino, I Boskoski, ... BMJ open gastroenterology 8 (1), e000578, 2021 | 64 | 2021 |
| How the gut parasitome affects human health G Ianiro, A Iorio, S Porcari, L Masucci, M Sanguinetti, CF Perno, ... Therapeutic advances in gastroenterology 15, 17562848221091524, 2022 | 51 | 2022 |
| Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center G Ianiro, S Bibbò, S Porcari, CR Settanni, F Giambò, AR Curta, ... Gut Microbes 13 (1), 1994834, 2021 | 45 | 2021 |
| A propensity score-matched comparison of infliximab and adalimumab in tumour necrosis factor-α inhibitor-naïve and non-naïve patients with Crohn’s disease: real-life data from … FS Macaluso, W Fries, AC Privitera, M Cappello, S Siringo, G Inserra, ... Journal of Crohn's and Colitis 13 (2), 209-217, 2019 | 34 | 2019 |
| Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders G Ianiro, JP Segal, BH Mullish, MN Quraishi, S Porcari, G Fabiani, ... Future microbiology 15 (12), 1173-1183, 2020 | 29 | 2020 |
| Future modulation of gut microbiota: from eubiotics to FMT, engineered bacteria, and phage therapy C Airola, A Severino, S Porcari, W Fusco, BH Mullish, A Gasbarrini, ... Antibiotics 12 (5), 868, 2023 | 26 | 2023 |
| Persistence on anti-tumour necrosis factor therapy in older patients with inflammatory bowel disease compared with younger patients: data from the Sicilian Network for … S Porcari, A Viola, A Orlando, AC Privitera, C Ferracane, M Cappello, ... Drugs & Aging 37, 383-392, 2020 | 22 | 2020 |
| Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: a prospective cohort study G Ianiro, S Bibbò, L Masucci, G Quaranta, S Porcari, CR Settanni, ... Digestive and Liver Disease 52 (12), 1390-1395, 2020 | 21 | 2020 |
| The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota M Fiorani, E Tohumcu, LE Del Vecchio, S Porcari, G Cammarota, ... Antibiotics 12 (4), 765, 2023 | 19 | 2023 |
| Histamine-producing bacteria and their role in gastrointestinal disorders M Fiorani, LE Del Vecchio, P Dargenio, F Kaitsas, T Rozera, S Porcari, ... Expert Review of Gastroenterology & Hepatology 17 (7), 709-718, 2023 | 18 | 2023 |
| Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank G Ianiro, S Porcari, S Bibbò, F Giambò, G Quaranta, L Masucci, ... Digestive and Liver Disease 53 (11), 1428-1432, 2021 | 16 | 2021 |
| Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis S Porcari, SMD Baunwall, AS Occhionero, MR Ingrosso, AC Ford, ... Journal of Autoimmunity 141, 103036, 2023 | 14 | 2023 |
| Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients 15: 2211 W Fusco, MB Lorenzo, M Cintoni, S Porcari, E Rinninella, F Kaitsas, ... | 14 | 2023 |
| Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis I Cacciola, G Russo, R Filomia, C Pitrone, G Caccamo, A Giandalia, ... Liver International 41 (9), 2059-2067, 2021 | 13 | 2021 |
| The role of faecal microbiota transplantation in chronic noncommunicable disorders BH Mullish, E Tohumcu, S Porcari, M Fiorani, N Di Tommaso, ... Journal of Autoimmunity 141, 103034, 2023 | 12 | 2023 |
| Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease LE Del Vecchio, M Fiorani, E Tohumcu, S Bibbò, S Porcari, MC Mele, ... Microorganisms 10 (7), 1315, 2022 | 12 | 2022 |
